WallStreetZenWallStreetZen

NASDAQ: KROS
Keros Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for KROS

Based on 1 analyst offering 12 month price targets for Keros Therapeutics Inc

Min Forecast
$18.00+61.15%
Avg Forecast
$18.00+61.15%
Max Forecast
$18.00+61.15%

Should I buy or sell KROS stock?

Based on 1 analyst offering ratings for Keros Therapeutics Inc.

Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although KROS's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates KROS as a "Strong Sell". Stocks with a Zen Rating of Strong Sell have had an average return of -12.86% per year. Learn More

Be the first to know when Wall Street analysts revise their KROS stock forecasts and price targets.

KROS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-08-04
lockedlocked$00.00+00.00%2026-08-04

1 of 1

Forecast return on equity

Is KROS forecast to generate an efficient return?

Company
-38.89%
Industry
18.55%
Market
169.71%
KROS's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is KROS forecast to generate an efficient return on assets?

Company
-35.47%
Industry
23.41%
KROS is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

KROS earnings per share forecast

What is KROS's earnings per share in the next 3 years based on estimates from 9 analysts?

Avg 1 year Forecast
-$5.65
Avg 2 year Forecast
-$6.36
Avg 3 year Forecast
-$4.78

KROS revenue forecast

What is KROS's revenue in the next 3 years based on estimates from 9 analysts?

Avg 1 year Forecast
$16.5M+9.61%
Avg 2 year Forecast
$610.2k-95.94%
Avg 3 year Forecast
$45.6M+203.64%
KROS's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

KROS revenue growth forecast

How is KROS forecast to perform vs Biotechnology companies and vs the US market?

Company
31.85%
Industry
32.37%
Market
13.52%
KROS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
KROS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

KROS vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
KROS$11.17$18.00+61.15%Strong Buy
TARA$3.75$27.00+620.00%Strong Buy
ELDN$2.71$12.00+342.80%Strong Buy
ZNTL$3.13$9.00+187.54%Strong Buy
AVXL$2.44$24.00+883.61%Strong Buy
View Top Biotech Stocks

Keros Therapeutics Stock Forecast FAQ

Is Keros Therapeutics Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: KROS) stock is to Strong Buy KROS stock.

Out of 1 analyst, 1 (100%) are recommending KROS as a Strong Buy, 0 (0%) are recommending KROS as a Buy, 0 (0%) are recommending KROS as a Hold, 0 (0%) are recommending KROS as a Sell, and 0 (0%) are recommending KROS as a Strong Sell.

If you're new to stock investing, here's how to buy Keros Therapeutics stock.

What is KROS's earnings growth forecast for 2026-2028?

(NASDAQ: KROS) Keros Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.31%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 31.35%.

Keros Therapeutics's earnings in 2026 is -$83,159,000.On average, 9 Wall Street analysts forecast KROS's earnings for 2026 to be -$111,981,975, with the lowest KROS earnings forecast at -$127,465,026, and the highest KROS earnings forecast at -$96,181,689. On average, 9 Wall Street analysts forecast KROS's earnings for 2027 to be -$126,108,847, with the lowest KROS earnings forecast at -$173,515,653, and the highest KROS earnings forecast at -$79,943,222.

In 2028, KROS is forecast to generate -$94,680,771 in earnings, with the lowest earnings forecast at -$177,207,475 and the highest earnings forecast at -$46,217,175.

What is KROS's revenue growth forecast for 2026-2028?

(NASDAQ: KROS) Keros Therapeutics's forecast annual revenue growth rate of 31.85% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 32.37%, and while it is forecast to beat the US market's average forecast revenue growth rate of 13.52%.

Keros Therapeutics's revenue in 2026 is $15,014,000.On average, 9 Wall Street analysts forecast KROS's revenue for 2026 to be $326,296,033, with the lowest KROS revenue forecast at $20,739,239, and the highest KROS revenue forecast at $424,698,367. On average, 9 Wall Street analysts forecast KROS's revenue for 2027 to be $12,097,836, with the lowest KROS revenue forecast at $0, and the highest KROS revenue forecast at $41,458,650.

In 2028, KROS is forecast to generate $903,881,847 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $2,081,854,740.

What is KROS's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: KROS) forecast ROA is -35.47%, which is lower than the forecast US Biotechnology industry average of 23.41%.

What is KROS's Price Target?

According to 1 Wall Street analyst that have issued a 1 year KROS price target, the average KROS price target is $18.00, with the highest KROS stock price forecast at $18.00 and the lowest KROS stock price forecast at $18.00.

The Wall Street analyst predicted that Keros Therapeutics's share price could reach $18.00 by Aug 4, 2027. The average Keros Therapeutics stock price prediction forecasts a potential upside of 61.15% from the current KROS share price of $11.17.

What is KROS's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: KROS) Keros Therapeutics's current Earnings Per Share (EPS) is -$3.22. On average, analysts forecast that KROS's EPS will be -$5.65 for 2026, with the lowest EPS forecast at -$6.43, and the highest EPS forecast at -$4.85. On average, analysts forecast that KROS's EPS will be -$6.36 for 2027, with the lowest EPS forecast at -$8.75, and the highest EPS forecast at -$4.03. In 2028, KROS's EPS is forecast to hit -$4.78 (min: -$8.94, max: -$2.33).

What is KROS's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: KROS) forecast ROE is -38.89%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.